Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 591056, 9 pages
http://dx.doi.org/10.1155/2013/591056
Review Article

An Emerging Role of Glucagon-Like Peptide-1 in Preventing Advanced-Glycation-End-Product-Mediated Damages in Diabetes

1Department of Internal Medicine, University of Genoa, Viale Benedetto XV 6, 16132 Genoa, Italy
2Division of Cardiology, Geneva University Hospitals, Faculty of Medicine, Foundation for Medical Researches, Avenue de la Roseraie 64, 1211 Geneva, Switzerland
3First Medical Clinic, Laboratory of Phagocyte Physiopathology and Inflammation, Department of Internal Medicine, University of Genoa, Viale Benedetto XV 6, 16132 Genoa, Italy

Received 8 October 2012; Revised 20 December 2012; Accepted 27 December 2012

Academic Editor: Dennis D. Taub

Copyright © 2013 Alessandra Puddu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Alessandra Puddu, François Mach, Alessio Nencioni, Giorgio Luciano Viviani, and Fabrizio Montecucco, “An Emerging Role of Glucagon-Like Peptide-1 in Preventing Advanced-Glycation-End-Product-Mediated Damages in Diabetes,” Mediators of Inflammation, vol. 2013, Article ID 591056, 9 pages, 2013. https://doi.org/10.1155/2013/591056.